Scarica l'app Stockscreener
166.42
1.56%
-2.63
Dopo l'orario di chiusura:
166.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$169.05
Aprire:
$166.87
Volume 24 ore:
678.95K
Relative Volume:
0.83
Capitalizzazione di mercato:
$9.37B
Reddito:
$633.51M
Utile/perdita netta:
$-8.10M
Rapporto P/E:
-536.84
EPS:
-0.31
Flusso di cassa netto:
$131.26M
1 W Prestazione:
+1.56%
1M Prestazione:
+3.49%
6M Prestazione:
+29.45%
1 anno Prestazione:
+7.58%
Intervallo 1D:
$164.19
$168.66
Intervallo di 1 settimana:
$162.21
$175.77
Portata 52W:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Confronta RGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
166.42 | 9.52B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
585.08 | 209.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.18 | 57.75B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.62 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.92 | 36.23B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
41.25 | 31.82B | 27.43B | 1.27B | 1.01B | 1.5829 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Iniziato | HSBC Securities | Buy |
| 2025-09-22 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
Can Repligen Corporation stock hit record highs againJuly 2025 Levels & AI Powered Market Trend Analysis - ulpravda.ru
Repligen appoints Madaus as new board chair, Hunt to retire By Investing.com - Investing.com Canada
Repligen Corporation Elects Dr. Martin D. Madaus as New Chair of the Board, Succeeding Tony Hunt - Quiver Quantitative
Institution Moves: How risky is Repligen Corporation RGN stock compared to peersMarket Risk Report & Risk Controlled Stock Pick Alerts - moha.gov.vn
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Pacer Advisors Inc. Has $1.37 Million Position in Repligen Corporation $RGEN - MarketBeat
Allspring Global Investments Holdings LLC Lowers Stake in Repligen Corporation $RGEN - MarketBeat
Delta Investment Management LLC Buys Shares of 50,717 Repligen Corporation $RGEN - MarketBeat
Repligen Corporation (NASDAQ:RGEN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Repligen Corporation stock remains undervaluedFibonacci Retracement Levels & Free Dynamic Capital Growth - bollywoodhelpline.com
Is Repligen (RGEN) Quietly Recasting Its Gene Therapy Moat With New HiPer Viral Vector Resins? - simplywall.st
Riverbridge Partners LLC Sells 24,644 Shares of Repligen Corporation $RGEN - MarketBeat
Congress Asset Management Co. Boosts Stake in Repligen Corporation $RGEN - Defense World
Assenagon Asset Management S.A. Takes Position in Repligen Corporation $RGEN - MarketBeat
Can Repligen Corporation stock maintain growth trajectoryFed Meeting & Smart Allocation Stock Tips - Улправда
Texas Permanent School Fund Corp Has $3.13 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Will Repligen Corporation stock rally after Fed decisions2025 Winners & Losers & Free Technical Pattern Based Buy Signals - Улправда
Why Repligen Corporation (RGN) stock trades below fair valueJuly 2025 Drop Watch & Risk Managed Investment Signals - Bölüm Sonu Canavarı
Repligen Corp’s results are impressive - uspostnews.com
Repligen (RGEN): Assessing Valuation After New Chromatography Resins Expand Its Gene Therapy Toolkit - simplywall.st
How institutional buying supports Repligen Corporation stockJuly 2025 Highlights & High Accuracy Investment Signals - Улправда
Insider Sell: Karen Dawes Sells Shares of Repligen Corp (RGEN) - GuruFocus
Repligen (NASDAQ:RGEN) Director Karen Dawes Sells 275 Shares - MarketBeat
REPLIGEN Director Karen A Dawes Sells 275 Shares - TradingView — Track All Markets
[Form 4] REPLIGEN CORP Insider Trading Activity - Stock Titan
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference - Yahoo Finance
Here’s Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN) - Insider Monkey
The Bull Case For Repligen (RGEN) Could Change Following New Gene Therapy Chromatography Resin Launches - simplywall.st
Repligen (RGEN) Expands Product Line with High-Performance Chrom - GuruFocus
Repligen Corporation Launches Three New High-Performance Chromatography Resins to Enhance Bioprocessing Solutions - Quiver Quantitative
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows - Yahoo Finance
RGEN: Wells Fargo Raises Repligen's Price Target to $190 | RGEN Stock News - GuruFocus
Repligen Corporation $RGEN Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Repligen Corporation $RGEN Shares Purchased by Squarepoint Ops LLC - MarketBeat
Holocene Advisors LP Reduces Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Ranger Investment Management L.P. Has $20.89 Million Holdings in Repligen Corporation $RGEN - MarketBeat
How analysts predict Repligen Corp (RGEN) will perform this quarter? - uspostnews.com
Repligen Corporation $RGEN Shares Purchased by First Trust Advisors LP - MarketBeat
What's Driving the Market Sentiment Around Repligen Corp? - Benzinga
The five-year earnings decline is not helping Repligen's (NASDAQ:RGEN share price, as stock falls another 3.3% in past week - Yahoo Finance
London & Capital Asset Management Ltd Lowers Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Norges Bank Buys New Holdings in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Sold by Baird Financial Group Inc. - MarketBeat
Nothing is Better Than Repligen Corp (RGEN) stock at the moment - setenews.com
Does Repligen Corporation (RGN) stock trade below intrinsic value2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Brown Capital Management LLC Has $125.04 Million Position in Repligen Corporation $RGEN - MarketBeat
State Street Premier Growth Equity V.I.S. Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Why Repligen Corporation stock is rated strong buyRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Schroder Investment Management Group Makes New $25.67 Million Investment in Repligen Corporation $RGEN - MarketBeat
Edgestream Partners L.P. Makes New $3.48 Million Investment in Repligen Corporation $RGEN - Defense World
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.26%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):